VAXXINOVA NORWAY AS
Operating
Forskning og utvikling, salg, markedsføring og teknisk støtte relatert
til veterinærmedisinske produkter og tjenester, spesielt biologiske
produkter for akvakulturindustrien, samt deltagelse i annen
forretningsvirksomhet.
Forskning og utvikling, salg, markedsføring og teknisk støtte relatert
til veterinærmedisinske produkter og tjenester, spesielt biologiske
produkter for akvakulturindustrien.
Organization
- CEO
- Chairman of the board
- Years since formation
- 16 years
- since Feb 16, 2010
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 23
Ownership
- Number of shares and share classes
- 100
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 17,677,316
- NOK
- Annual total result 2025
- -24,561,742
- NOK
- Total equity 2025
- 892,504
- NOK
Last update: Jul 21, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
| Chairman | - | |
| Board Member | - | |
| Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Last update: Dec 3, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 100 | 100 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 17,677,316 | 14,391,172 | 12,749,043 | 10,426,726 |
Annual Total Result | -24,561,742 | -23,232,304 | -20,230,756 | -12,941,261 |
Total assets | 78,687,559 | 74,336,056 | 61,932,112 | 20,628,173 |
Total liabilities | 77,795,056 | 48,881,811 | 46,600,810 | 20,066,116 |
Total equity | 892,504 | 27,098,999 | 15,331,303 | 562,058 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 17,677,316 | 14,391,172 | 12,749,043 | 10,426,726 |
Total operating costs | 53,220,242 | 43,030,990 | 38,065,129 | 27,118,674 |
Operating result | -35,542,926 | -28,639,818 | -25,316,086 | -16,691,948 |
Financial income/costs | 3,106,209 | -1,805,001 | -1,257,180 | -6,129 |
Profit before tax | -32,436,718 | -30,444,818 | -26,573,266 | -16,698,077 |
Total tax & extraordinary income/cost | -7,874,976 | -7,212,514 | -6,342,510 | -3,756,816 |
Annual Total Result | -24,561,742 | -23,232,304 | -20,230,756 | -12,941,261 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 53,503,537 | 52,759,618 | 44,116,785 | 9,270,825 |
Total current assets | 25,184,022 | 21,576,438 | 17,815,327 | 11,357,349 |
Total assets | 78,687,559 | 74,336,056 | 61,932,112 | 20,628,173 |
Short term debt | 12,480,370 | 14,085,609 | 33,007,243 | 3,755,107 |
Long term debt | 65,314,686 | 34,796,202 | 13,593,567 | 16,311,009 |
Total liabilities | 77,795,056 | 48,881,811 | 46,600,810 | 20,066,116 |
Contributed capital | 95,189,372 | 95,189,372 | 60,189,372 | 25,189,372 |
Retained earnings | -94,296,868 | -68,090,374 | -44,858,069 | -24,627,314 |
Total equity | 892,504 | 27,098,999 | 15,331,303 | 562,058 |
Total equity and liabilities | 78,687,559 | 75,980,809 | 61,932,113 | 20,628,174 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification